Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. Tober-Lau P, Gruell H, Vanshylla K, Koch WM, et al. Emerg Infect Dis 2022;28.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tober-Lau P, Gruell H, Vanshylla K, Koch WM, et al. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. Emerg Infect Dis 2022;28.
PMID: 35259088